BPL-03™
Bonded Phospholipids-Omega 3 technology
Scientifically backed
Omega-3 for real-life
performance.
Ruby-O® is a unique technology
designed for delivering Omega-3, inspired
by how the human body naturally
receives and uses nutrients
It is not simply another
Omega-3 with
higher concentration
or optimized ratios.
Ruby-O® represents a fundamentally different way of thinking about omega-3, one that starts from human biology, not from the label.
At its core, Ruby-O® respects how nature delivers omega-3 to the human body and intentionally emulates the body’s own processes to carry it efficiently to tissues and cells.
This is made possible through BPL-03™(Bonded Phospholipid Omega-3), Ruby-O®’s patented molecular architecture, where omega-3 is structurally associated with phospholipids, the same lipid structures that form cell membranes and regulate nutrient entry at the cellular level.
Ruby-O® does not force
the body to adapt to Omega-3
It adapts Omega-3
to the body.
Why Omega-3
Needs to Be Reframed
Omega-3 is one of the most researched nutrients in the world, yet its real-world effectiveness is often limited by a single overlooked factor: bioavailability.
For decades, the Omega-3 category has focused on milligrams, concentrations, and label claims. But biology does not respond to dosage alone. Omega-3 must be absorbed, transported, and ultimately incorporated into tissues and cell membranes to deliver meaningful benefits.
Health Starts at the Cell
Every biological function in the human body begins at the cellular level.
Each cell is surrounded by a phospholipid membrane, a dynamic structure that controls:
What enters the cell
How nutrients are recognized
How signals are transmitted
Why Phospholipids Are Essential to
Omega-3 Performance
Phospholipids are structural lipids, not additives. They:
Form the foundation of all cell membranes
Enable lipid transport through blood and tissues
Support brain, cardiovascular, liver, and metabolic health
Allow omega-3 to integrate directly into the lipid bilayer
In contrast, traditional fish oil requires enzymatic cleavage and reassembly, increasing metabolic cost and variability.
Back to the Roots of Omega-3
The Inuit Insight
The first benefits of omega-3 were not discovered in supplements.
They were observed in real human populations. When researchers studied Inuit communities in Greenland, they found strong health outcomes despite diets rich in fat.
Over time, science understood that the benefit was not only how much omega-3 they consumed, but how omega-3 was consumed through food.
In cold-water fish, omega-3 is not delivered as an isolated oil. It is naturally delivered together with phospholipids, structures the human body already recognizes and uses. This led to a fundamental insight:
Omega-3 was never
meant to work alone.
The form in which omega-3 is delivered helps
the body recognize it, transport it, and use it.
Ruby-O® applies modern lipid science to this ancestral biological truth, created after years of science and research to bring omega-3 back to its natural delivery logic, while enhancing it through modern science.
Over more than five years of research and development, Ruby-O was designed to imitate the natural way omega-3 travels in the body, while applying advanced purification, biotechnology, and processing.
But Ruby-O goes one step further.
Biomimetic Design Principle:
The Ruby-O Way
Designed Like the Body Works
Biomimetic design means intentionally emulating natural biological systems.
Ruby-O® BPL-O3™ is biomimetic because it:
Uses phospholipid architectures similar to human cell membranes
Mimics natural lipid transport and uptake pathways
Reduces reliance on digestive conversion
Delivers omega-3 in a biologically familiar structure
Rethinking Omega-3 Bioavailability
Acute and Chronic Matter
True omega-3 effectiveness depends on two complementary phases:
Rethinking Omega-3 Bioavailability
Acute and Chronic Matter
True omega-3 effectiveness depends on two complementary phases:
Immediate bioavailability
how fast EPA and DHA
appear in blood.
Chronic bioavailability:
how efficiently omega-3 is
incorporated into cell
membranes over time
Faster Absorption
Early Peak Uptake vs Krill Oil
Clinical data shows Ruby-O® achieves:
Significantly higher plasma EPA+DHA levels in the first peak hours
Faster uptake than krill oil and other omega-3 formats
Sustained plasma presence over 24 hours
This confirms that molecular architecture matters, even within phospholipid Omega-3.
Clinical Evidence:
The Ruby-O® Balance Clinical Study
When Molecular Design Delivers
Measurable Outcomes
The Ruby-O® Balance study was designed to address a critical and often overlooked question in omega-3 research:
Can molecular delivery design improve biological utilization of omega-3, even at a lower dose?. To answer this, Ruby-O® BPL-03™ was evaluated in a randomized, controlled human study against a conventional fish oil control, using different daily EPA+DHA doses.
Ruby-O® BPL-O3™ group
825 mg/day EPA+DHA, delivered
in a bonded phospholipid
(BPL-O3™) architecture
Control fish oil group
903 mg/day EPA+DHA, delivered
as conventional omega-3 oil
Despite receiving less total EPA+DHA per day, the Ruby-O® group was designed to test whether biomimetic delivery, not higher dosage, could drive superior biological outcomes.
Key Clinical Findings
Together, these findings demonstrate that delivery architecture plays a decisive role in omega-3 performance, enabling Ruby-O® to achieve greater biological impact with less omega-3.
Why This Study
Is Groundbreaking
Most omega-3 solutions attempt to compensate for poor utilization by increasing the dose.
The Ruby-O® Balance study shows a different path forward: optimize how omega-3 is delivered, recognized, and incorporated by the body.
This represents a shift from dose-driven supplementation to biology-driven omega-3 performance.
What Independent Media
Say About the Science
“Naturmega’s biomimetic Ruby-O improves omega-3 delivery for heart health by focusing on bioavailability rather than simple dosage.”
-Nutrition Insight
(source: Nutrition Insight, Jan 2026)
“Naturmega’s Ruby-O shows a bioavailability edge over standard fish oil in a peer-reviewed clinical trial.”
-PharmaDeviceNews
(source: Nutrition Insight, Jan 2026)
Ongoing
Clinical Research
Ruby-O®’s clinical program is active and expanding, exploring new biomarkers, health pathways, and applications of the BPL-O3™ platform.
More to come
A Unique, Versatile
Lipid Architecture,
Unlike Any Other
Designed to Adapt Omega-3 to Different
Biological Needs
Ruby-O® BPL-03™ is not defined by a single formulation, a fixed concentration, or a one-size-fits-all delivery system.
By integrating phospholipids directly into its molecular design, Ruby-O® enables omega-3 to be structured differently depending on the intended need, creating a unique and highly versatile lipid architecture that has no equivalent in today’s omega-3 market.
This architectural flexibility allows Ruby-O® to move beyond generic delivery and into purpose-designed omega-3 performance, guided by biology rather than dosage.
What This
Unique Architecture Enables
Through its bonded phospholipid omega-3 (BPL-O3™) architecture, Ruby-O®
can be intentionally designed to support:
Different/optimized concentrations
Allowing efficiency-driven formulations without relying on dose escalation
Different/tailored delivery priorities
Adapting absorption. transport, and utilization to specific biological objectives
Different/specific target tissues
Supporting tissue-relevant delivery where omega-3 demand is highest
Different/optimized health applications
Aligning omega-3 architecture with distinct physiological and metabolic needs
Different / specialized sources
Enabling formulation flexibility across marine and alternative omega-3 sources
This level of structural adaptability is not possible with
conventionaltriglyceride or ethyl ester omega-3 formats.
Designed for
Key Health Categories
Because of this unique, versatile lipid architecture, Ruby-O® BPL-O3™
supports innovation across:
Not by changing the story,
but by changing the structure behind it.
Supported by
Broader Scientific Evidence
Ruby-O® BPL-O3™ builds on a growing body of published research showing
that phospholipid-bound omega-3 can:
Improve bioavailability versus traditional triglyceride oils
Enhance tissue incorporation of EPA and DHA
Support brain and liver uptake
